## On January 2, 2018, Baltimore Company purchased 20,000 shares of the stock of Towson Company at \$10 per share.

On January 2, 2018, Baltimore Company purchased 20,000 shares of the stock of Towson Company at \$10 per share. Baltimore obtained significant influence as the purchase represents a 40% ownership stake in Towson Company. On August 1, 2018, Towson Company paid cash dividends of \$25,000. Baltimore Company intended this investment to a long-term investment. On December 31, 2018, Towson Company reported \$75,000 of net income for FY 2018. Additionally, the current market price for Towson Company’s stock increased to \$28 per share at the end of the year. Use this information to determine, how much Baltimore Company should report for its investment in Towson Company on December 31, 2018.
On January 2, 2018, Baltimore Company purchased 6,000 shares of the stock of Towson Company at \$12 per share. Baltimore did NOT obtain significant influence as the purchase represents a 10% ownership stake in Towson Company. On August 1, 2018, Towson Company paid cash dividends of \$23,000. Baltimore Company intended this investment to a long-term investment. On December 31, 2018, Towson Company reported \$75,000 of net income for FY 2018. Additionally, the current market price for Towson Company’s stock increased to \$27 per share at the end of the year. Use this information to determine, how much Baltimore Company should report for its investment in Towson Company on December 31, 2018.

## We will build and test a simple long only trading strategy. First, obtain daily data of “SPY” from 2010- 10-01 to 2016-02-19. Compute the daily log…

We will build and test a simple long only trading strategy. First, obtain daily data of “SPY” from 2010- 10-01 to 2016-02-19. Compute the daily log return using the adjusted closing price. Divide the dataset into two parts: the first 1254 for training and the rest 100 days as holdout samples. library(quantmod) source(“backtest.r”) getSymbols(“SPY”,from=’2010-10-01′,to=’2016-02-19′,src=”yahoo”) (a) Construct the best ARMA model based on the first 1254 daily log return data using the auto.arima function in the fpp package. This function will automatically select the best orders (namely p, d, and q in the arima model) for you. We call this model 1. We will then fix the order of the arima model, and at each step, only parameter estimation changes. Use this model to predict one day ahead. Compare the predicted direction (namely if the prediction return is positive or negative) with the direction of the actual return. Were you right? For the next day re-estimate the parameters using data 2 to 1255 and predict the next day’s direction. Repeat until the test data is exhausted. Report the probability of being correct (calculated as the percentage of times the model predicts the directions correctly). (b) Now, look at the ACF plot of the training data only, propose an MA(q) model. Look at the PACF plot of the training data only, propose an AR(p) model. Please give your reasons for choosing the p and q values. Call these model 2 and 3. Compare these three models using backtest procedure to compare the models via 1-step ahead forecasts. You may use t = 1254 as the starting forecast origin. Which one has the best accuracy?

Here is the backtest code to be pasted in r for this question’s use!

“backtest” <- function(m1,rt,orig,h=1,xre=NULL,fixed=NULL,include.mean=TRUE){

# m1: is a time-series model object

# orig: is the starting forecast origin

# rt: the time series

# xre: the independent variables

# h: forecast horizon

# fixed: parameter constriant

# inc.mean: flag for constant term of the model.

#

regor=c(m1\$arma[1],m1\$arma[6],m1\$arma[2])

seaor=list(order=c(m1\$arma[3],m1\$arma[7],m1\$arma[4]),period=m1\$arma[5])

nT=length(rt)

if(orig > nT)orig=nT

if(h < 1) h=1

rmse=rep(0,h)

mabso=rep(0,h)

nori=nT-orig

err=matrix(0,nori,h)

jlast=nT-1

if(!is.null(xre))xre <- matrix(xre)

for (n in orig:jlast){

jcnt=n-orig+1

x=rt[1:n]

if (is.null(xre))

pretor=NULL else pretor=xre[1:n,]

mm=arima(x,order=regor,seasonal=seaor,xreg=pretor,fixed=fixed,include.mean=include.mean)

if (is.null(xre)){nx=NULL}

else {nx=matrix(xre[(n+1):(n+h),],h,ncol(xre))}

fore=predict(mm,h,newxreg=nx)

kk=min(nT,(n+h))

# nof is the effective number of forecats at the forecast origin n.

nof=kk-n

pred=fore\$pred[1:nof]

obsd=rt[(n+1):kk]

err[jcnt,1:nof]=obsd-pred

}

#

for (i in 1:h){

iend=nori-i+1

tmp=err[1:iend,i]

mabso[i]=sum(abs(tmp))/iend

rmse[i]=sqrt(sum(tmp^2)/iend)

}

print(“RMSE of out-of-sample forecasts”)

print(rmse)

print(“Mean absolute error of out-of-sample forecasts”)

print(mabso)

backtest <- list(origin=orig,error=err,rmse=rmse,mabso=mabso)

}

## Vanda Pharmaceutical is a biopharmaceutical company with a focus on the development and commercialization of clinical-stage product candidates for…

Vanda Pharmaceutical is a biopharmaceutical company with a focus on the development and commercialization of clinical-stage product candidates for central nervous system disorders. On July 28, 2008 the company was waiting for FDA response on a Drug Approval Application submitted for “iloperidone”, an investigational atypical antipsychotic that was reviewed for the treatment of schizophrenia. We will analyze FDA approval implications on Vanda stock price using binomial trees.

Today, t=0, is July 28, 2007; in 1 year time, that is t=1, depending on whether FDA approves the drug application, analysts believe that Vanda stock price can either be S1,u = 21 with probability q=0.7 or S1,d = 10 with probability (1-q) = 0.3. Assume that the firm has a CAPM beta equal to 2, that the annualized continuously-compounded risk-free rate is 5%, and that the annually-compounded expected excess return on the market (or market risk premium) is 6.44%.

(1)  What is the expected return on the stock according to the CAPM? (Tip: note that the risk-free rate provided is continuously-compounded, but in the CAPM equation you need to plug the annually-compounded equivalent). (2 points)

(2)  Use your answer in part (1) to compute the value S0  of the stock on July 28, 2007, that is one year before FDA’s approval decision (Tip: recall, asset values are discounted expectations of future cash flows). (2 points)

(3)  Compute the value of an at-the money European call option with maturity t=1 using the risk-neutral methodology. (6 points)

(i)            Compute the risk-neutral probabilities.

(ii)           Compute the expected stock price at time t=1 (July 28, 2008) under the risk neutral probabilities.

(iii)         Compute the expected stock price at time t=1 (July 28, 2008) under the probabilities assumed by the analysts. Are the two time t=1 expected prices computed above equal/different? Discuss.

(iv)          Compute the option value under the risk-neutral probabilities.

(4)  Assume that the strike price is equal to the time t=0 stock price computed in point (2) above. How would the value of the option computed in Point (3) change if …. (6 points)

(i)            The probability (assumed by the analysts) that FDA approves the drug becomes 80%? Provide some intuition.

(ii)           The probability (assumed by the analysts) that FDA approves the drug becomes 80% and the CAPM beta of the firm becomes 3.14? Provide some intuition.

(5)  What is the value of an at-the-money European put option? (3 points)

(6)  What is the value of an at-the-money forward contract? (3 points)

## i am looking for a second opinion on the question, Should the e-business function have its own chief who reports to the CEO?

i am looking for a second opinion on the question, Should the e-business function have its own chief who reports to the CEO?100 words or more no fromat needed

i am looking for a second opinion on the question, Should the e-business functionhave its own chief who reports to the CEO?150 wordsSolution:e-business has become the most important part of any…

## DUE IN 3 HOURS!!!!!!!!!

Joining the ranks of a profession

This week as you reach the end of this term and program, discuss with your classmates how you have moved closer to identifying yourself as an NP. Specifically, what are some ways that you can support this profession?

Include at least 300 words with 3 intext citations no older than 3 years.

## Nursing

• Describe how the roles of the community health nurse as research and educator might overlap.
• How are the roles of consultant and educator alike? What is the key difference?
• Identify examples in your community in which nurses act as: Advocates, case managers, and counselors.

## Topic Cancer

The American Cancer Society (ACS) is a nationwide, community-based, voluntary health organization dedicated to eliminating cancer as a major health problem. Together with its supporters, ACS is committed to helping people stay well and get well by finding cures and by fighting back.
Critical Thinking Questions:
1. Imagine that a family friend or colleague has just been diagnosed with cancer. Explain how the American Cancer Society might provide education and support. What ACS services would you recommend and why?
2. According to statistics published by the American Cancer Society, there will be an estimated 1.5 million new cancer cases diagnosed each year over the next decade. What factors contribute to the yearly incidence and mortality rates of various cancers in Americans? What changes in policy and practice are most likely to affect these figures over time
3. Select a research program from among those funded by the American Cancer Society. Describe the program and discuss what impact the research will have on the prevention or treatment of cancer.

## Class 1 Momment 1

Advanced practice nursing has grown and developed through the guidance of different frameworks and models helping to define one group of nurses from another. Acknowledging and licensing nurses who go beyond the basic skills set of nurses started the journey of advancement. Hamric developed a model that would apply to all the different advanced practice nurse roles to define characteristics to support the growth of the practice. All of the elements in the model Hamric designed are essential in providing optimal potential. The top three that I find most important are direct clinical practice, clinical and professional leadership, and ethical decision making.

Direct clinical practice is imperative to the definition of APN. It is one of the central competencies identified in the Hamric model. The nursing training, bed side care and hands on approach is what sets APN aside from other mid-level practitioners in the medical field. The better the direct clinical practice the better the patient or research outcome will be.

Clinical and professional leadership is the second element of the nursing model that I chose. Advanced practice nursing provides the umbrella term for all nurse specialists. If it were not for nurse leaders we would not have the developed system that allow us to practice at the graduate level. Professionally we need nurse involvement at the local, regional and national organization levels. Leadership goes far beyond patient care, it incorporates a certain advocacy as well. Leaders need to be strong and confident, balanced with critical thinking skills, and goal focused.

The last characteristic I chose is ethical decision making. APN enables much more autonomy than a registered nurse. Ethical decision making blends technical data and clinical knowledge with emotional and spiritual knowledge. It is a very gray area that tends to go beyond evidence based practice. “A problem becomes an ethical or moral problem issues of core values or fundamental obligations are present” (Hamric, 2014). An APN needs to have strength and competence in order to make the appropriate decision. This can be a deciding factor in the outcome of treatment or patient goals.

Reference

Hamric, A., Hanson, C., Tracy, M., & O’Grady, E. (2014). Advanced Practice Nursing: An Integrative

Approach. (5 ed.). St. Louis: Saunders.

## Class 1 Comment 2

Hamric’s model of advanced practice nursing was created in 1996 and is composed of seven core components (Hamric, 2014). The three elements of Hamric’s definition of advanced nursing practice that I think are most important are; collaboration, evidence-based practice and leadership.

Initially, collaboration is important in nursing practice because in our field we have to collaborate with each other every day to give the patient the best care possible. Communicating with the attending doctors, nursing assistants and other staff members can ensure for a more positive outcome for patients. If we don’t work together as a team and collaborate with each other the patients are not going to receive the treatment they need in a timely fashion.

Secondly, evidence-based practice is also a key element for advanced practice nursing. The three main components of EBP, research, clinical expertise and patient preferences can help improve outcomes (Understanding Evidence-Based Practice, 2016). By following this, proven research allows for a quicker and more affective diagnosis and treatment of patients.

Lastly, leadership as other elements of Hamric’s models of advanced practice nursing is a crucial piece for advanced nursing. A good leader is focused on what is best for patients, staff and their organization. Doing so will ensure better outcomes and satisfaction in the work place for both patients and staff.

References

Hamric, A.,Hanson, C., Tracy, M., & O’Grady, E. (2014). Advanced Practice Nursing: An Integrative Approach. (5thed.). St. Louis: Sanders

Understanding Evidence-Based Practice. (2016). Retrieved May 20, 2017, from http://www.nursingcenter.com/evidencebasedpracticenetwork/home/tools-resources/collections/understandingevidencebasedpractice.aspx

Filter by:

## First Draft

The practice of health care providers at all levels brings you into contact with people from a variety of faiths. This calls for knowledge and acceptance of a diversity of faith expressions.

The purpose of this paper is to complete a comparative analysis of two faith philosophies towards providing health care, one being the Christian perspective. For the second faith, choose a faith that is unfamiliar to you. Examples of faiths to choose from: Sikh, Baha’i, Buddhism, Shintoism, etc.

In a minimum of 1,500-2,000 words, provide a comparative analysis of the different belief systems, reinforcing major themes with insights gained from your research.

In your comparative analysis, address all of the worldview questions in detail for Christianity and your selected faith.  Refer to chapter 2 of the Called to Care for the list of questions.  Be sure to address the implications of these beliefs for health care.

In addition answer the following questions that address the practical and healthcare implications based on the research:

1. What are critical common components to all religions/beliefs in regards to  healing, such as prayer, meditation, belief, etc.? Explain.
2. What is important to patients of the faiths when cared for by health care providers whose spiritual beliefs differ from their own?

In your conclusion, describe your own spiritual perspective on healing, what you have learned from the research and how this learning can be applied to a health care provider.

Support your position by referencing at least three academic resources (preferably from the GCU Library) in addition to the course readings, the Bible, and the textbooks for each religion. Each religion must have a primary source included. A total of six references are required according to the specifications listed above.  Incorporate the research into your writing in an appropriate, scholarly manner.

Prepare this assignment according to the APA guidelines found in the APA Style Guide, located in the Student Success Center. An abstract is required.

This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.